||
CRISPR/Cas9技术改造供体T细胞,试图治疗患有耐药性白血病的重症儿童,否则这些儿童已经用尽了所有可用的治疗方法。 https://www.ebiotrade.com/newsf/2022-10/20221028032732194.htm
看看 主题词
http://www.pubmedplus.cn/P/SearchQuickResult?wd=5a6f5ec3-21ca-41ed-bd57-47aee986e674
01. | 无法确认 | 1 篇 | 3.704% |
02. | 2022 | 4 篇 | 14.815% |
03. | 2021 | 4 篇 | 14.815% |
04. | 2020 | 4 篇 | 14.815% |
05. | 2019 | 3 篇 | 11.111% |
06. | 2018 | 3 篇 | 11.111% |
07. | 2016 | 1 篇 | 3.704% |
08. | 2013 | 1 篇 | 3.704% |
09. | 2009 | 1 篇 | 3.704% |
10. | 2008 | 2 篇 | 7.407% |
01. | oncol rep | 6 篇 | 22.222% |
02. | mol med rep | 3 篇 | 11.111% |
03. | haematologica | 2 篇 | 7.407% |
04. | int j oncol | 2 篇 | 7.407% |
05. | acta pharmacol sin | 1 篇 | 3.704% |
06. | asian pac j cancer prev | 1 篇 | 3.704% |
07. | biol blood marrow transplant | 1 篇 | 3.704% |
08. | cancer genet | 1 篇 | 3.704% |
09. | indian j hematol blood transfus | 1 篇 | 3.704% |
10. | inn med (heidelb) | 1 篇 | 3.704% |
01. | 中国 | 10 篇 | 37.037% |
02. | 日本 | 4 篇 | 14.815% |
03. | 德国 | 3 篇 | 11.111% |
04. | 埃及 | 1 篇 | 3.704% |
05. | 俄罗斯 | 1 篇 | 3.704% |
06. | 荷兰 | 1 篇 | 3.704% |
07. | 克罗地亚 | 1 篇 | 3.704% |
08. | 马来西亚 | 1 篇 | 3.704% |
09. | 以色列 | 1 篇 | 3.704% |
10. | 印度 | 1 篇 | 3.704% |
01. | 中国北京 | 2 篇 | 7.407% |
02. | 中国杭州 | 2 篇 | 7.407% |
03. | 中国上海 | 1 篇 | 3.704% |
04. | 中国徐州 | 1 篇 | 3.704% |
05. | 中国青岛 | 1 篇 | 3.704% |
06. | 中国新乡 | 1 篇 | 3.704% |
07. | 中国重庆 | 1 篇 | 3.704% |
08. | 中国台北市 | 1 篇 | 3.704% |
01. | Humans | 22 篇 | 81.481% |
02. | Female | 8 篇 | 29.630% |
03. | Apoptosis | 6 篇 | 22.222% |
04. | Cell Line, Tumor | 6 篇 | 22.222% |
05. | Male | 5 篇 | 18.519% |
06. | T-Lymphocytes | 5 篇 | 18.519% |
07. | Cell Proliferation | 4 篇 | 14.815% |
08. | Immunotherapy, Adoptive | 4 篇 | 14.815% |
09. | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 篇 | 14.815% |
10. | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 篇 | 14.815% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-10-20 06:25
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社